| http://www.w3.org/ns/prov#value | - ing binding of said polypeptide to said sample, and (c) comparing the binding detected in step (b) with a standard, wherein a difference in binding relative to said sample is diagnostic of a disorder characterized by aberrant signaling of EGFR. Another embodiment of the present invention is a method of diagnosing a disorder characterised by the presence of IGF-IR comprising:(a) contacting a sample
|
